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1. lnhxiuction 
Probing active sites of enzymes by electron spin 
resonance using spin-labelled coenzyme analogues has 
been exploited by several groups [l-6] . Useful infor- 
mation concerning binary complexes of the enzymes 
with the analogues and ternary complexes with addi- 
tional substrates orsubstrate-like compounds can often 
be obtained by such studies. 
NAD’ with a spin-label linked to the amino group 
of the adenine moiety (N”SLNAD+) was synthesized 
by us [4] and has been used in binding studies with 
lactate dehydrogenase [5] and glutamate dehydro- 
genase [6] . 
In this paper we describe the synthesis of 8SL-NAD+ 
in which the spin-label is bound via an amino func- 
tion to C-8 of the coenzyme (fig.1). The dinucleotide 
has been prepared by condensation of nicotinamide 
mononucleotide and 8SL-AMP in presence of dicyclo- 
hexylcarbodiimide [7]. 
This new attachment of the spin-label to the 
coenzyme is particularly interesting because bulky 
substituents atC-8 of adenine nucleotides are known 
to favour a syn-conformation of the base relative to 
the ribose ring, in contrast o N6-substituents which 
hesented in part at the Jahrestagung der Deutschen Gesell- 
schaft ti Biophysik in Regensburg, 1976 
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Fig.1. Structure of the 8-spin-labelled nucleotides. 
obviously do not affect the predominant anti-confor- 
mation of the unsubstituted compounds [8]. Thus, 
8SLNAD’ is expected to be a useful complement of 
N%LNAD’ in many cases. 
2. Experimental 
2.1. Materials 
Lactate dehydrogenase (EC 1.1.1.27) from pig 
heart, alcohol dehydrogenase (EC 1.1 .l . 1) from yeast, 
nicotinamide mononucleotide (free acid) and NAD* 
were purchased from Boehringer, Mannheim. 
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2.2. General procedures 
Thin-layer chromatography was carried out on pre- 
coated silica gel 60 Fa+, plates from Merck, Darmstadt, 
in the following systems: (A) Isopropanol/l% aqueous 
ammonium sulfate (2: 1, v/v); (B) Isobutyric acid/cone. 
ammonia/water (66: 1: 33, v/v/v). 
Coenzyme reductions, catalyzed by the two dehy- 
drogenases, were followed by the increase in absor- 
bance at 366 nm (e = 3330 M-i. cm-‘). 
Reaction conditions: Buffer, 0.2 M glycine/NaOH, 
pH 9.5; Substrates, 0.1 M lactate or 0.3 M ethanol; 
Coenzymes, concentrations varied from 7 X lo-’ M 
to 8 X IO4 M. The reactions were initiated by addi- 
tion of 0.4 E.cg lactate dehydrogenase or 0.2 pg alcohol 
dehydrogenase, r spectively. Total volume, 400 /.d. 
Temperature, 25°C. 
Km- and V,, -values were determined according to 
the method of Lineweaver and Burk [9 ] . 
The concentration of lactate dehydrogenase (mol. 
wt tetramer = 144 000) was determined spectrophoto- 
metrically: E: zrnl (280 nm) = 1.4 in 67 mM phos- 
phate buffer, pH 7.2; ESR spectra were recorded on a 
X-band spectrometer at25°C. 
The ESR titration experiments were carried out as 
described previously [S] . 
2.3. Syntheses 
2.3.1.8-(2,2,6,6-tetramethylpiperidin4-yl-l-oxyl)Amino 
adenosine 5’-phosphate (8SL-AMP) 
426 mg (1 mmol) 8.bromoadenosine 5’-phosphate 
(free acid) [lo] were dissolved in 50 ml water, and 
the pH was adjusted to 6.9 with 1 M NaOH. After 
addition of 700 mg (4.1 mmol) 4-amino-2,2,6,6-tetra- 
methylpiperidine-1-oxyl, the solution was kept in a 
sealed tube at 1 IO’C for 40 h. The crude product was 
purified on DEAE-Sephadex A-25 (column, 
2 X 25 cm, acetate form). Elution with water was 
followed by a linear gradient of 600 ml each of water 
and a pyridinium acetate buffer (I M acetic acid, 
1.5 M pyridine). 8SLAMP eluted after 420 ml of the 
gradient and was lyophilized. Rechromatography 
under similar conditions and lyophilization yielded 
90 mg (17%) of the pure product. 
&, = 278 mn, E = 18 400 M-i. cm-’ in 67 mM 
phosphate buffer, pH 7.2. 
Anal. calcd. for Ci9H3iN70sP (516.47): 
C, 44.19; H, 6.05; N, 18.98; P, 6.00 
Found: C,44.10;H,6.10:N, 18.82;P,5.94 
Thin-layer chromatography: System A, RF = 0.53; 
System B, RF = 0.50. 
2.3.2. Nicotinamide 8-(2,2,6,6_tetramethylpiperidin- 
4-~1-1 oxyl)amino adenine dinucleotide (8SL- 
NAD+) 
10 ml pyridine and then 0.5 g N#-dicyclohexyl- 
carbodiimide were added to a solution of 37 mg 
(72 ~01) 8-(2,2,6,6-tetramethylpiperidin4-yl-l-oxyl) 
amino adenosine 5’-phosphate and 33 mg (99 ~01) 
nicotinamide mononucleotide in 2.5 ml water. The 
solution was stirred for 24 h at room temperature and 
then separated from precipitated icyclohexylurea 
which was extracted with 0.5 ml hot water. Another 
0.5 g carbodiimide was added to the combined filtrate 
and extract which was stirred for further 24 h. This 
process was repeated four times, the last two addi- 
tions of carbodiimide being 0.2 g only. 
Finally the solution was poured into 70 ml water. 
After 3 h the solution was filtered and carefully 
extracted with chloroform. The organic phase was 
washed with water and the combined aqueous phases 
were concentrated to about 10 ml under reduced 
pressure and separated on DEAE-Sephadex A-25 
(column, 1.5 X 95 cm, chloride form). Elution was 
carried out with water and subsequently with a linear 
gradient of 900 ml water and 900 ml 0.2 M lithium 
chloride. 8SL-NAD* eluted after 680 ml of the 
gradient. The fraction was lyophilized and triturated 
with ethanol/ether (1:3) to remove the LiCl. The 
remaining crude dinucleotide was rechromatographed 
under similar conditions and isolated as described 
above. A final purification was achieved by precipi- 
tation from methanol with a 5-fold volume of ether 
at 0°C. 
Yield: 6 mg (10%). 
Lax = 274 mn, E = 22 300 M-r. cm-’ in 67 mM phos- 
phate buffer, pH 7.2. 
Thin-layer chromatography: System A, RF = 0.37; 
System B, RF = 0.43. 
Efforts to isolate nzymaticahy reduced spin-labelled 
NADH were unsuccessful, due to slow redox reactions 
involving the dihydropyridine- and the nitroxyl-part of 
the coenzyme analogue. Qualitative ESR measurements 
of SL-NADH could, however, be carried out when the 
compound was prepared in situ in the ESR flat cell 
from SLNAD+ by reduction with ethanol and catalytic 
amounts of alcohol dehydrogenase at alkaline pH. 
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3. Results and discussion 
3.1. Enzyme kinetic data 
A crucial question inherent to spin-labelling is to 
what extent an attached spin-label perturbs the bio- 
logical system under investigation [ 1 l] . In the case 
of spin-labelled coenzymes one obvious way to 
answer this question is to determine their kinetic para- 
meters. The results with the NAD+-analogues and two 
dehydrogenases are summarized in table 1. 
In the lactate dehydrogenase ystem N”SLNAD+ 
proves to be a nearly perfect coenzyme analogue; 
Km- and V,,-values are very similar to those of 
NAD’. The correspondence in the case of alcohol 
dehydrogenase from yeast, which is known to be a 
rather specific enzyme, is good as well. 
A different behaviour is observed with 8SL-NAD’. 
Its Michaelis constants are of the same magnitude as 
those of NAD+; however, the maximum velocities 
are considerably smaller. A likely explanation for 
these differences i  the preferred syn-conformation 
of the 8SGadenosine moiety in solution. 
For lactate dehydrogenase it could be shown with 
molecular models of 8SL-NAD’ and the enzyme 2.5 A 
resolution that binding of the analogue can occur exclu- 
sively in the anti-conformation (Eventoff, W. and 
Rossmann, M. G., personal communication). Thus, the 
isomerization may be rate limiting. 
3.2. ESR Spectra 
8SLNAJl+ in buffer shows the expected ‘nitroxyl- 
triplet’ with the slightly broadened high-field line 
typical for spin-labelled molecules of that size (fig.2). 
The addition of lactate dehydrogenase causes the 
amplitudes of all three lines to decrease. With increased 
instrumental gain the components of an ‘immobihzed 
spectrum’, resulting from the fraction of 8SL-NAD’ 
bound to the enzyme, can be seen (tig3a). 
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Fig.2. ESR spectrum of 4.4 X lo-’ M 8SL-NAD* in 67 mM 
phosphate buffer, pH 7.2. Relative instrument gain: 1. 
When the spin-labelled coenzyme is reduced by 
ethanol and catalytic amounts of alcohol dehydro- 
genase the contribution from the ‘immobilized spec- 
trum’ drastically increases (fIg3b), indicative of an 
almost complete binding of 8SLNADH to lactate 
dehydrogenase under these conditions, i.e., 1.35-fold 
excess of possible binding sites over the coenzyme 
analogue. The distance between the outer peaks in 
fig.3 is about 65 G, still 2 G higher than in the 
corresponding complexes of N%LNAD [5] . Splitting 
of this size shows a highly restricted environment of 
the nitroxyl group on the enzyme. This again is in 
accordance with the X-ray structure. There is suffi- 
cient space for the spin-label when 8SLNAD is bound 
in the anti-conformation. However, movement of the 
nitroxyl group relative to the adenine base is reduced 
to a minor wobbling. In the case of lactate dehydro- 
genase/N%L-NAD complexes the motional freedom 
of the spin-label seems to be somewhat less con- 
strained. 
3.3. Binding parameters 
The amplitude of the triplet high-field line is pro- 
Table 1 
Kinetic parameters of NAD+ and its spin-labelled analogues 
Coenzyme 
NAD+ 
N6 SL-NAD+ 
8SL-NAD+ 
Lactate dehydrogenase Alcohol dehydrogenase 
Km 04) V max (%I Km (M) V mm (%I 
0.7 x 10-4 100 2.4 X lo-’ 100 
0.8 X lo-’ 71 5.6 X lo-’ 65 
1.2 x lo-’ 7 6.7 x lo-’ 13 
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Fig.3. ESR Spectra of the binary lactate dehydrogenase com- 
plexes with SSL-NAD+ and SSL-NADH in 0.1 M Tris/HCl 
buffer, pH 9.5. Relative instrument gain: 53. Curve a: 
2.2 X lo-’ M 8SL-NAD; 7.5 X lo-’ M lactate dehydrogenase; 
3.6 X lo-* Methanol. Curve b: 2.1 X lo-* M 8SL-NAD; 
7.1 X lo-’ M lactate dehydrogenase; 3.4 X 10-l M ethanol; 
8 X lo-’ M alcohol dehydrogenase. Th  vertical rrows indi- 
cate the positions ofthe outer peaks of the ‘immobilized 
spectra’. 
portional to the concentration of unbound radical 
because the ‘immobilized spectrum’ does not contri- 
bute significantly to this line. Hence it is possible to 
titrate lactate dehydrogenase with the spin-labelled 
coenzymes [5] . The results for 8SLNAD+ are shown 
as a Scatchard plot [ 12 ] in fig.4. 
It can be deduced that 8SLNAD’ is bound to the 
four coenzyme-binding sites of the tetrameric enzyme 
with a dissociation constant of 7.6 X lo4 M. This 
value is slightly higher than the value of 5.6 X lo4 M 
found for N’%LNAD’ [S] , in accordance with the 
kinetic results. The dissociation constant for NAD’ 
is about 3 X lo4 M [13]. 
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Fig.4. Scatchard plot of the ESR titration data for 8SL-NAD+ 
binding to lactate dehydrogenase. 67 mM phosphate buffer, 
pH 7.2. Enzyme concentration: 6.0 X 10T5 M. 8SL-NAD+ 
concentration varied from 2.8 X lo-’ M to 1.2 X 10s3 M. 
8SL-NADH is bound tighter by about two orders of 
magnitude by lactate dehydrogenase than the oxidized 
analogue, as can be estimated from the ESR-signal 
amplitudes. Similar results have been obtained with 
N%L-NADH. A detailed binding study could not be 
carried out due to slow reduction of the spin-label 
by,the dihydronicotinamide ring. The natural coen- 
zyme NADH itself is known to bind about 360-times 
more tightly to the enzyme than NAD’ [ 131, which 
is in accordance with our findings. Spin-labelled 
coenzymes have been extremely valuable for studying 
various ternary complexes of lactate dehydrogenase 
[ 141. The results will be summarized elsewhere. 
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